Mary Elizabeth Strek to Antifibrinolytic Agents
This is a "connection" page, showing publications Mary Elizabeth Strek has written about Antifibrinolytic Agents.
Connection Strength
0.119
-
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29; 370(22):2083-92.
Score: 0.119
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.